Literature DB >> 21288778

Quality of life following epilepsy surgery for children with tuberous sclerosis complex.

Jonathan Roth1, Adeolu Olasunkanmi, William S MacAllister, Emily Weil, Catherine C Uy, Orrin Devinsky, Howard L Weiner.   

Abstract

Parents of children with tuberous sclerosis complex who underwent multistage resections for treatment of refractory seizures were offered a telephone questionnaire regarding quality of life (QOL) of child and family since surgery. Of 53 families, 39 responded. Age at epilepsy onset was birth to 3 months. Average duration of epilepsy before the first surgery was 5.1 years, and average age at surgery was 5.8. The average follow-up was 3.9. Seventy-seven percent had a >90% reduction in disabling seizures. In all outcome categories, 46-85% had at least a moderate improvement in QOL. There was a significant correlation between QOL variables and Engel outcome class. Despite the potential burden posed by the aggressive surgical approach, including multiple surgeries and long hospitalization periods, 94% of parents would choose the same course once again. We conclude that aggressive surgical treatment of tuberous sclerosis complex-related refractory seizures is associated with significant control of epilepsy as well as improved QOL for the patient and family.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21288778     DOI: 10.1016/j.yebeh.2010.11.003

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  8 in total

1.  Surgery for epilepsy.

Authors:  Siobhan West; Sarah J Nevitt; Jennifer Cotton; Sacha Gandhi; Jennifer Weston; Ajay Sudan; Roberto Ramirez; Richard Newton
Journal:  Cochrane Database Syst Rev       Date:  2019-06-25

2.  Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex.

Authors:  Menno Vergeer; Wendela L de Ranitz-Greven; Maureen P Neary; Raluca Ionescu-Ittu; Bruno Emond; Mei Sheng Duh; Floor Jansen; Bernard A Zonnenberg
Journal:  Epilepsia Open       Date:  2019-10-27

Review 3.  A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC).

Authors:  Johann Philipp Zöllner; David Neal Franz; Christoph Hertzberg; Rima Nabbout; Felix Rosenow; Matthias Sauter; Susanne Schubert-Bast; Adelheid Wiemer-Kruel; Adam Strzelczyk
Journal:  Orphanet J Rare Dis       Date:  2020-01-21       Impact factor: 4.123

Review 4.  The research landscape of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)-a comprehensive scoping review.

Authors:  Stephanie Vanclooster; Stacey Bissell; Agnies M van Eeghen; Nola Chambers; Liesbeth De Waele; Anna W Byars; Jamie K Capal; Sebastián Cukier; Peter Davis; Jennifer Flinn; Sugnet Gardner-Lubbe; Tanjala Gipson; Tosca-Marie Heunis; Dena Hook; J Christopher Kingswood; Darcy A Krueger; Aubrey J Kumm; Mustafa Sahin; Eva Schoeters; Catherine Smith; Shoba Srivastava; Megumi Takei; Robert Waltereit; Anna C Jansen; Petrus J de Vries
Journal:  J Neurodev Disord       Date:  2022-02-13       Impact factor: 4.025

Review 5.  Tuberous sclerosis complex: Five new things.

Authors:  David T Hsieh; Susan L Whiteway; Luis O Rohena; Elizabeth A Thiele
Journal:  Neurol Clin Pract       Date:  2016-08

6.  Brain-Responsive Neurostimulation for the treatment of adults with epilepsy in tuberous sclerosis complex: A case series.

Authors:  Danielle S McDermott; Emily A Mirro; Kirsten Fetrow; David E Burdette; Stephanie Chen; Jennifer Hopp; Todd Masel; Emily A Johnson; Felicia M K Elefant; Scheherazade Le; Sanjay E Patra; Mesha-Gay Brown; Zulfi Haneef
Journal:  Epilepsia Open       Date:  2021-03-13

7.  Changing global trends in seizure outcomes following resective surgery for tuberous sclerosis in children with medically intractable epilepsy.

Authors:  George M Ibrahim; Aria Fallah; O Carter Snead; James T Rutka
Journal:  Epilepsy Res Treat       Date:  2012-11-25

8.  Patient and Caregiver Health State Utilities in Tuberous Sclerosis Complex.

Authors:  Siu Hing Lo; Jade Marshall; Hanna Skrobanski; Andrew Lloyd
Journal:  Pharmacoecon Open       Date:  2021-09-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.